Product Images Caprelsa
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Caprelsa NDC 58468-7820 by Genzyme Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - caprelsa 01
Figure 1 - caprelsa 02
PRINCIPAL DISPLAY PANEL - 100 mg Tablet Bottle Label - caprelsa 03
This is a medication label for Caprelsa (Vandetanib) tablets, manufactured in Switzerland by Genzyme Gorporation. The label includes dosage instructions, warnings to keep the medication out of reach of children, and storage instructions. It also includes the manufacturer's contact information and the NDC (National Drug Code). The medication guide is enclosed with the package and should be dispensed to each patient.*
PRINCIPAL DISPLAY PANEL - 100 mg Tablet Bottle Carton - caprelsa 04
Caprelsa is a medication in tablet form containing vandetanib. It is used for treating specific types of thyroid cancer. The prescription comes with a medication guide that is to be given to each patient. Caprelsa is registered under the trademark of Genzyme Corporation and manufactured in Switzerland. The tablets should be stored at room temperature between 68°F and 77°F (20°C and 25°C) with permitted excursions allowed to 59°F-86°F (15°C-30°C). The prescription should be kept out of reach of children. For more information, contact Genzyme support services at 1-800-745-4447 (Option 3).*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.